scispace - formally typeset
H

Helen Chim

Researcher at Harvard University

Publications -  7
Citations -  1492

Helen Chim is an academic researcher from Harvard University. The author has contributed to research in topics: Insulin receptor & Sirtuin 1. The author has an hindex of 7, co-authored 7 publications receiving 1302 citations.

Papers
More filters
Journal ArticleDOI

PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress

TL;DR: It is reported that the oncogenic melanocyte lineage-specification transcription factor MITF drives PGC1α (PPARGC1A) overexpression in a subset of human melanomas and derived cell lines.
Journal ArticleDOI

The cAMP/PKA Pathway Rapidly Activates SIRT1 to Promote Fatty Acid Oxidation Independently of Changes in NAD +

TL;DR: A cAMP-induced phosphorylation of a highly conserved serine (S434) located in the SIRT1 catalytic domain that rapidly enhanced intrinsic deacetylase activity independently of changes in NAD(+) levels is identified.
Journal ArticleDOI

Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression

TL;DR: This work reports that in mice insulin activates cyclin D1–cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression, and identifies a Cdk4 inhibitor that potently decreases PGC-1α acetylation.
Journal ArticleDOI

Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling

TL;DR: It is shown that chronic rapamycin treatment in mice led to insulin resistance with suppression of insulin/IGF signaling and genes associated within this pathway, such as Igf1-2, Irs1-1, and Akt1-3, and that skeletal muscle-specific YY1 knockout mice were protected fromRapamycin-induced diabetic-like symptoms.